Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry G M Heijerman

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Respiratory Research|December 3, 2022
Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasisLotte C Terpstra, Josje Altenburg, Inez Bronsveld, et al.
Journal of the Academy of Nutrition and Dietetics|September 19, 2017
Body Weight and Body Mass Index in Patients with End-Stage Cystic Fibrosis Stabilize After the Start of Enteral Tube FeedingFrancis M Hollander, Nicole M de Roos, Gerdien Belle van Meerkerk, et al.
Journal of Personalized Medicine|January 27, 2026
Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic FibrosisBente L Aalbers, Gimano D Amatngalim, Ellen M Aarts, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 2, 2008
Aerosolization of tobramycin (TOBI) with the PARI LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressorElsbeth M Westerman, Anne H De Boer, Daan J Touw, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 3, 2018
Prevalence of severe fatigue among adults with cystic fibrosis: A single center studyMerel M Nap-van der Vlist, Marcella Burghard, H J Hulzebos, et al.
Therapeutic Advances in Respiratory Disease|January 11, 2022
Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitationMarcella Burghard, Tim Takken, Merel M Nap-van der Vlist, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2024
Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction studyRenske van der Meer, Erik B Wilms, Margot N Eggermont, et al.
Intensive Care Medicine|March 7, 2006
Outcome of assisted ventilation for acute respiratory failure in cystic fibrosisMartijn G Slieker, Josephus P J van Gestel, Harry G M Heijerman, et al.
Genetic Testing|April 1, 2008
CFTR mutations in Turkish and North African cystic fibrosis patients in Europe: implications for screeningPhillis Lakeman, Johan J P Gille, Jeannette E Dankert-Roelse, et al.
Eclinicalmedicine|August 9, 2023
Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic FibrosisDanya Muilwijk, Tessa J van Paridon, Doris C van der Heijden, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Respiratory Research|December 3, 2022
Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasisLotte C Terpstra, Josje Altenburg, Inez Bronsveld, et al.
Journal of the Academy of Nutrition and Dietetics|September 19, 2017
Body Weight and Body Mass Index in Patients with End-Stage Cystic Fibrosis Stabilize After the Start of Enteral Tube FeedingFrancis M Hollander, Nicole M de Roos, Gerdien Belle van Meerkerk, et al.
Journal of Personalized Medicine|January 27, 2026
Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic FibrosisBente L Aalbers, Gimano D Amatngalim, Ellen M Aarts, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 2, 2008
Aerosolization of tobramycin (TOBI) with the PARI LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressorElsbeth M Westerman, Anne H De Boer, Daan J Touw, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 3, 2018
Prevalence of severe fatigue among adults with cystic fibrosis: A single center studyMerel M Nap-van der Vlist, Marcella Burghard, H J Hulzebos, et al.
Therapeutic Advances in Respiratory Disease|January 11, 2022
Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitationMarcella Burghard, Tim Takken, Merel M Nap-van der Vlist, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2024
Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction studyRenske van der Meer, Erik B Wilms, Margot N Eggermont, et al.
Intensive Care Medicine|March 7, 2006
Outcome of assisted ventilation for acute respiratory failure in cystic fibrosisMartijn G Slieker, Josephus P J van Gestel, Harry G M Heijerman, et al.
Genetic Testing|April 1, 2008
CFTR mutations in Turkish and North African cystic fibrosis patients in Europe: implications for screeningPhillis Lakeman, Johan J P Gille, Jeannette E Dankert-Roelse, et al.
Eclinicalmedicine|August 9, 2023
Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic FibrosisDanya Muilwijk, Tessa J van Paridon, Doris C van der Heijden, et al.
Pageof 5